IL51669A - Substituted 2-(4-(haloprop-2-yl)anilino)-2-oxazolines and thiazolines - Google Patents

Substituted 2-(4-(haloprop-2-yl)anilino)-2-oxazolines and thiazolines

Info

Publication number
IL51669A
IL51669A IL51669A IL5166977A IL51669A IL 51669 A IL51669 A IL 51669A IL 51669 A IL51669 A IL 51669A IL 5166977 A IL5166977 A IL 5166977A IL 51669 A IL51669 A IL 51669A
Authority
IL
Israel
Prior art keywords
haloprop
thiazolines
oxazolines
anilino
substituted
Prior art date
Application number
IL51669A
Other versions
IL51669A0 (en
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/668,385 external-priority patent/US4081547A/en
Priority claimed from US05/731,236 external-priority patent/US4103018A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of IL51669A0 publication Critical patent/IL51669A0/en
Publication of IL51669A publication Critical patent/IL51669A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL51669A 1976-03-19 1977-03-16 Substituted 2-(4-(haloprop-2-yl)anilino)-2-oxazolines and thiazolines IL51669A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/668,385 US4081547A (en) 1974-12-02 1976-03-19 Para-polyfluoroisopropyl-anilino-2-oxazoline compounds, pharmaceutical compositions and method of treating hypertension
US05/731,236 US4103018A (en) 1976-10-12 1976-10-12 2-[4-(Polyhalo-2-hydroxy-2-propyl)anilino]-2-oxazolin-4-ones and thiazolin-4-ones corresponding thereto

Publications (2)

Publication Number Publication Date
IL51669A0 IL51669A0 (en) 1977-05-31
IL51669A true IL51669A (en) 1980-10-26

Family

ID=27099887

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51669A IL51669A (en) 1976-03-19 1977-03-16 Substituted 2-(4-(haloprop-2-yl)anilino)-2-oxazolines and thiazolines

Country Status (9)

Country Link
JP (1) JPS52113960A (en)
AU (1) AU506147B2 (en)
CH (1) CH626356A5 (en)
DE (1) DE2711330A1 (en)
FR (1) FR2344548A1 (en)
GB (1) GB1532351A (en)
IE (1) IE44791B1 (en)
IL (1) IL51669A (en)
NL (1) NL7702846A (en)

Also Published As

Publication number Publication date
IE44791L (en) 1977-09-19
AU2335577A (en) 1978-09-21
FR2344548B1 (en) 1978-12-29
AU506147B2 (en) 1979-12-13
DE2711330A1 (en) 1977-09-22
CH626356A5 (en) 1981-11-13
GB1532351A (en) 1978-11-15
JPS52113960A (en) 1977-09-24
IL51669A0 (en) 1977-05-31
IE44791B1 (en) 1982-04-07
NL7702846A (en) 1977-09-21
FR2344548A1 (en) 1977-10-14

Similar Documents

Publication Publication Date Title
NZ188041A (en) 2-(p-alkoxyphenoxy)-pyridine derivatives and herbicidal compositions
IT1155800B (en) REPLACED IMIDAZOLS AND TRIAZOLES
NL7803036A (en) 4- (5-FLUORMETHYL-2-PYRIDYLOXY) PHENOXYALCANE CARBONIC ACIDS AND DERIVATIVES THEREOF.
DK156479C (en) 2- (2-fluoro-4-halo-5-substituted-phenyl) -HYDANTOINDERIVATER
FI780954A (en) 5- (4- (DIARYLMETHYL) -1-PIPERAZINYLALKYL) BENZENIMIDAZOLE DERIVATIVES
IT1156737B (en) IMIDAZOAZINICI AND IMIDAZODIAZINICI COMPOUNDS
NZ183450A (en) Preparation of the crystalline -form of 2-(4-(2-foroyl)-piperazin-1-yl)-4-amino-6,7-dimethoxy-quinazdine hydrochloride
HK96887A (en) 4-(naphthyl-methyl)piperidine derivatives
FI790019A (en) PROCEDURE FOR THE FRAMSTATION OF AV 4- (61-METOXY-21-NAPHTHYL) BUTAN-2-ON WITH ANTIINFLAMMATORISK AKTIVITET
BE890265A (en) N - (4- (PYRIDYL 3-SUBSTITUE) PIPERAZINO) ALKYL) AZASPI-RODECANEDIONES
NZ187066A (en) 4-(3-substitutedamino-2-hydroxypropoxy)-benzimidazolidin-2-(ones or thiones)
IL52706A0 (en) 4-((4-diphenylmethyl-1-piperidinyl)methyl) benzeneamines and their preparation
PH11387A (en) N-(2-(pyridinyl)-4-pyrimidinyl)ureas
DK255279A (en) PIPERIDINE DERIVATIVES OF 1,3,5-TRIAZOXYCLOHEPTANE-2,4-DION AND PROCEDURES FOR THE MANUFACTURE AND USE OF THESE
FI802323A (en) FALSK BOTTEN FOER KAERL
DK111479A (en) MOLDING MACHINE AND USE OF THE SAME
GB2056447B (en) 4-(naphthalenyloxy) piperidine derivatives
IL51669A (en) Substituted 2-(4-(haloprop-2-yl)anilino)-2-oxazolines and thiazolines
FI811610L (en) FOERFARANDE FOER FRAMSTAELLNING AV 4- (3-IODOPROPARGYLOXI) PYRIMIDINDERIVAT
BE852348A (en) 2- (2-ACETAMIDO-2-DEOXY-3-0-D-GLUCOPYRANOSYL) -D-PROPIONYL-L-SERYL-D-ISOGLUTAMINE
PH13260A (en) 4-(1-hydroxy-1-nethylethyl)-3-cyclorexen-1-one derivative
IT7824909A0 (en) PROCEDURE AND EQUIPMENT FOR THE TREATMENT OF HOT SOFTENABLE MATERIALS.
FI772743A (en) FOERFARANDE FOER FRAMSTAELLNING AV 2- (PHENYLALKYLHYDRAZONO) -PROPIONSYRADERIVAT
FI800106A (en) FOERFARANDE FOER SEPARERING AV D, 1 2- (6-METOXY-2-NAPHTHYL) PROPIONYRA
NZ183935A (en) 2-(2-alkyl or cycloalkylphenyl)-imino thiazolines